Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells
- PMID: 16309236
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells
Abstract
Background: Butyric acid is a short chain fatty acid produced by large bowel bacterial flora. It serves as an antiinflammatory agent and nutrient for normal colon cells. Butyric acid has also been shown to induce apoptosis in colon and many other cancer cells. Artemisinin is a compound extracted from the wormwood Artemisia annua L. It has been shown to selectively kill cancer cells in vitro and to be effective in treating animal and human cancer. We and others have found that the artemisinin analog, dihydroartemisinin (DHA), kills cancer cells by apoptosis. In the present study, the efficacy of a combined treatment of DHA and butyric acid at low doses in killing cancer cells was investigated.
Materials and methods: Molt-4 cells (a human lymphoblastoid leukemia cell line) and freshly isolated human lymphocytes, cultured in complete RPMI-1640 medium, were first incubated with 12 microM of human holotransferrin at 37 degrees C in a humid atmosphere of 5% CO2 for one hour to enhance the iron concentration in the cells. Cells from each cell type were then divided into 20 flasks. These flasks were grouped into four sets of five cultures each. Zero, 5, 10 or 20 microM of DHA was added, respectively, to these sets and the cells were incubated at 37 degrees C for one hour. Zero, 1, 5, 10, or 20 mM of sodium butyrate was then added to the five cultures of each set, respectively. Thus, the treatments involved a combination of 4 doses of DHA and 5 doses of sodium butyrate. The cells were counted immediately before the addition of DHA, and at 24 and 48 hours after the addition of sodium butyrate.
Results: DHA alone at the 24-hour time-point and 20 microM concentration significantly reduced the number of Molt-4 cells in the culture by approximately 40% (p < 0.001, compared to non-treated control), whereas it did not significantly affect the number of normal human lymphocytes. Similarly, 1 mM sodium butyrate alone at 24 hours reduced the number of Molt-4 cells by approximately 32% (p < 0.001, compared to non-treated control), without significantly affecting normal human lymphocytes. The combination of 20 microM DHA and 1 mM sodium butyrate killed all Molt-4 cells at the 24-hour time-point and did not significantly affect lymphocytes.
Conclusion: DHA in combination with butyric acid acts synergistically at low doses. The combination may provide a less toxic, inexpensive and effective cancer chemotherapy.
Similar articles
-
Artemisinin induces apoptosis in human cancer cells.Anticancer Res. 2004 Jul-Aug;24(4):2277-80. Anticancer Res. 2004. PMID: 15330172
-
Additive cytotoxic effects of dihydroartemisinin and sodium salicylate on cancer cells.Anticancer Res. 2014 Jul;34(7):3399-401. Anticancer Res. 2014. PMID: 24982346
-
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.Anticancer Res. 2014 Jun;34(6):2807-10. Anticancer Res. 2014. PMID: 24922643
-
Cancer combination therapies with artemisinin-type drugs.Biochem Pharmacol. 2017 Sep 1;139:56-70. doi: 10.1016/j.bcp.2017.03.019. Epub 2017 Mar 31. Biochem Pharmacol. 2017. PMID: 28366726 Review.
-
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.Expert Opin Ther Targets. 2005 Oct;9(5):995-1007. doi: 10.1517/14728222.9.5.995. Expert Opin Ther Targets. 2005. PMID: 16185154 Review.
Cited by
-
Butyrate: More Than a Short Chain Fatty Acid.Curr Nutr Rep. 2023 Jun;12(2):255-262. doi: 10.1007/s13668-023-00461-4. Epub 2023 Feb 10. Curr Nutr Rep. 2023. PMID: 36763294 Review.
-
Short-Chain Fatty Acid Butyrate Induces Cilia Formation and Potentiates the Effects of HDAC6 Inhibitors in Cholangiocarcinoma Cells.Front Cell Dev Biol. 2022 Jan 13;9:809382. doi: 10.3389/fcell.2021.809382. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35096835 Free PMC article.
-
Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo.Am J Pathol. 2021 Oct;191(10):1822-1836. doi: 10.1016/j.ajpath.2021.06.005. Epub 2021 Jun 29. Am J Pathol. 2021. PMID: 34214507 Free PMC article.
-
Artemisinin-type drugs for the treatment of hematological malignancies.Cancer Chemother Pharmacol. 2021 Jan;87(1):1-22. doi: 10.1007/s00280-020-04170-5. Epub 2020 Nov 3. Cancer Chemother Pharmacol. 2021. PMID: 33141328 Review.
-
Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms.Theranostics. 2019 Sep 17;9(22):6631-6645. doi: 10.7150/thno.33353. eCollection 2019. Theranostics. 2019. PMID: 31588240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources